Drop the weight.
Not your confidence.
Doctor-prescribed GLP-1, WhatsApp coaching, and home delivery. Real results, no crash diets.
Find out if GLP-1 is right for you
Answer 6 questions and get a personalised medication recommendation, reviewed by a doctor.
No credit card · No obligation · Results in 2 minutes
Find out if GLP-1 is right for you
Answer 6 questions and get a personalised medication recommendation, reviewed by a doctor.
No credit card · No obligation · Results in 2 minutes
The same medicine behind Ozempic & Wegovy.
Up to 15% average weight loss in clinical trials · Prescribed by NMC-registered doctors
Proven medicine, prescribed responsibly.
The clinical evidence matters more to us than a wall of testimonials.
Proven in trials
In the STEP and SURMOUNT trials, semaglutide averaged around 15% body-weight loss and tirzepatide around 20% over roughly a year, alongside diet and lifestyle changes.
A doctor decides
An NMC-registered doctor reviews your health profile and bloodwork before anything is prescribed. Sometimes the honest answer is no.
Handled safely
Every medication is CDSCO-approved, dispensed by a licensed pharmacy, and shipped cold-chain at 2 to 8°C to your door.
Five steps.
No clinic queue.
Designed for people with full lives, not full waiting rooms.
Real specialist.
Assessment
BMI, history, goals. No clinic, no forms that go nowhere.
Doctor call
A real NMC-registered physician, not a GP, not a chatbot.
Prescription
Clinical judgement, not a checkout. Right dose for your profile.
Home delivery
Medication dispatched from a licensed pharmacy to your door.
Ongoing support
A macro tracker that grades each meal against your plan, regular WhatsApp check-ins, and dose adjustments as you go.
Want to find out if GLP-1 is right for you?
Free · 2 minutes · No commitment
Clear pricing.
Branded Ozempic runs ₹10,000–14,000/month. ALTRcare starts at ₹3,499/month, the same molecule, with a doctor managing every dose.
- ✓Generic semaglutide, delivered
- ✓Cold-chain home delivery
- ✓Monthly doctor follow-ups
- ✓Dose adjustments included
- ✓Cancel anytime
- ✓Full dosing escalation protocol
- ✓Cold-chain home delivery
- ✓Monthly doctor follow-ups
- ✓1 at-home blood test included
- ✓Full dosing escalation protocol
- ✓Priority WhatsApp support
- ✓Diet & nutrition guidance
- ✓2 at-home blood tests included
Semaglutide is titrated up over 8–12 weeks, longer plans reflect how the treatment actually works. Every dose is included at one price.
Bloodwork at home
Baseline blood panel worth ₹800–1,000, done at home, no clinic visit
NMC-registered doctors
Board-certified physicians review every case before prescribing
No lock-in
Cancel or pause anytime, no forms, no phone calls, no lock-in period.
The science behind GLP-1
Phase III Indian trial confirms semaglutide is effective and safe in Indian adults with obesity, the "Asian Indian phenotype" responds well at lower BMI thresholds.
Tirzepatide achieved up to 22.5% weight reduction, the largest seen in any obesity pharmacotherapy trial to date.
254 million Indian adults have generalised obesity. Indians carry more visceral fat at lower BMIs, metabolic risk starts earlier than Western guidelines suggest.
Research Society for Study of Diabetes in India recommends GLP-1 receptor agonists as preferred therapy for Indian patients with obesity-related cardiovascular risk.
Individual results vary. GLP-1 medications are prescribed only when clinically appropriate based on your health profile and bloodwork.
We're with you, or we make it right
Every ALTRcare plan is backed by straightforward promises, not fine print.
30-Day Satisfaction Promise
Not happy in your first 30 days with the service? Contact your care team and we'll make it right by adjusting your plan, changing your support team, or refunding anything not yet dispatched. No awkward conversations.
No Long-Term Lock-In
Cancel or pause your plan anytime via WhatsApp, no forms, no phone calls, no waiting on hold. We keep you because the programme works, not because you're locked in.
The 30-day satisfaction promise covers service quality, not clinical outcomes, which depend on your health profile and adherence. GLP-1 medications are prescribed only when clinically appropriate.
Help a friend lose weight.
You both get rewarded.
Share your personalised referral link with a friend. When they join any ALTRcare plan, you both get ₹1,000 off your next month, automatically applied by your care team.
No limit on referrals. Stack discounts month after month.
Share on WhatsApp
Tap the button below to send your unique referral message to a friend.
Friend joins ALTRcare
They mention your name when they sign up. Our team verifies it.
You both save ₹1,000
Discount applied to your next month and their first month.
Discount verified manually by your care team within 24 hours of your friend's sign-up.
Frequently asked questions
Everything you need to know before you start.
Safety & approval
About the programme
Payments & cancellations
Referrals
The GLP-1 Guide for India
Evidence-based articles for patients, doctors, and the curious.
Weight LossWhy You're Not Losing Weight in a Calorie Deficit
Eating 1,500 calories and still stuck? Your hormones, not your willpower, may be setting the terms. Here's what insulin resistance actually does to fat loss.
Metabolic HealthYour BMI Is Normal, but Your Belly Fat Is Dangerous
Indians develop metabolic disease at far lower body weights than the global BMI chart suggests. Here's the biology behind it and what it means for your health.
Medication GuideSemaglutide vs Tirzepatide: Which GLP-1 Is Right for You?
Both drugs work. But tirzepatide averages 20–22% weight loss vs 15% for semaglutide, and costs significantly more. Here's how doctors decide.
PCOSPCOS and Weight Loss: How GLP-1 Breaks the Cycle
Insulin resistance drives PCOS weight gain, and GLP-1 medications directly target insulin signalling. Here's the clinical evidence and what to expect.
Cost & AccessWhy a Branded Weight-Loss Pen Costs ₹16,000 When the Molecule Costs ₹1,500
The molecule is now commodity-cheap in India. So what is the branded Ozempic price tag actually buying you?
Diabetes & MetabolicPre-Diabetes in India: How GLP-1 Can Reverse It Before It's Too Late
136 million Indians have pre-diabetes. Most don't know. GLP-1 therapy has been shown to reverse pre-diabetes in 60–80% of patients.
Ready to fix
your biology?
Doctor-prescribed GLP-1, delivered to your door.